The Replication Crisis in Epidemiology: Snowball, Snow Job, or Winter Solstice?
暂无分享,去创建一个
[1] T. Sterling. Publication Decisions and their Possible Effects on Inferences Drawn from Tests of Significance—or Vice Versa , 1959 .
[2] A. B. Hill. The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.
[3] C B Begg,et al. A measure to aid in the interpretation of published clinical trials. , 1985, Statistics in medicine.
[4] K J Rothman,et al. Significance questing. , 1986, Annals of internal medicine.
[5] K J Rothman,et al. A strengthening programme for weak associations. , 1988, International journal of epidemiology.
[6] A R Feinstein,et al. Scientific standards in epidemiologic studies of the menace of daily life. , 1988, Science.
[7] A R Feinstein,et al. A collection of 56 topics with contradictory results in case-control research. , 1988, International journal of epidemiology.
[8] J. Utts. Replication and Meta-Analysis in Parapsychology , 1991 .
[9] G. Colditz,et al. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence☆☆☆ , 1991 .
[10] S. Cummings,et al. Hormone therapy to prevent disease and prolong life in postmenopausal women , 1992, Annals of internal medicine.
[11] Casual inference. , 1993, Epidemiology.
[12] G. Taubes. Epidemiology faces its limits. , 1995, Science.
[13] N. Kerr. HARKing: Hypothesizing After the Results are Known , 1998, Personality and social psychology review : an official journal of the Society for Personality and Social Psychology, Inc.
[14] D. Weed. Epidemiologic evidence and causal inference. , 2000, Hematology/oncology clinics of North America.
[15] J. Palmgren,et al. Sinistrality—a side-effect of prenatal sonography: A comparative study of young men , 2001, Epidemiology.
[16] C D Holman,et al. A Psychometric Experiment in Causal Inference to Estimate Evidential Weights Used by Epidemiologists , 2001, Epidemiology.
[17] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[18] D. Petitti. Hormone replacement therapy and coronary heart disease: results of randomized trials. , 2003, Progress in cardiovascular diseases.
[19] R. Lemen. Chrysotile Asbestos as a Cause of Mesothelioma: Application of the Hill Causation Model , 2004, International journal of occupational and environmental health.
[20] Shah Ebrahim,et al. Commentary: the hormone replacement-coronary heart disease conundrum: is this the death of observational epidemiology? , 2004, International journal of epidemiology.
[21] John Hoey,et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. , 2004, JAMA.
[22] Ida Sim,et al. Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1) , 2005, BMJ : British Medical Journal.
[23] A. Gelman,et al. The Difference Between “Significant” and “Not Significant” is not Itself Statistically Significant , 2006 .
[24] Sander Greenland,et al. Why Most Published Research Findings Are False: Problems in the Analysis , 2007, PLoS medicine.
[25] S. Pocock,et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.
[26] J. Ioannidis. Why Most Discovered True Associations Are Inflated , 2008, Epidemiology.
[27] James M. Robins,et al. Observational Studies Analyzed Like Randomized Experiments: An Application to Postmenopausal Hormone Therapy and Coronary Heart Disease , 2008, Epidemiology.
[28] G Maldonado,et al. Adjusting a relative-risk estimate for study imperfections , 2008, Journal of Epidemiology and Community Health.
[29] J. Brooks. Why most published research findings are false: Ioannidis JP, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece , 2008 .
[30] Paolo Vineis,et al. Epidemiology, Public Health, and the Rhetoric of False Positives , 2009, Environmental health perspectives.
[31] Tony Tse,et al. Registration of observational studies: Is it time? , 2010, Canadian Medical Association Journal.
[32] S. Cole,et al. Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial. , 2010, American journal of epidemiology.
[33] Trish Groves,et al. Registration of observational studies , 2010, BMJ : British Medical Journal.
[34] G. Bedogni. Applying Quantitative Bias Analysis to Epidemiologic Data , 2011 .
[35] Sander Greenland,et al. Causation and Causal Inference , 2021, International Encyclopedia of Statistical Science.
[36] M. Bracken. Preregistration of epidemiology protocols: a commentary in support. , 2011, Epidemiology.
[37] K. Salvesen. Ultrasound in pregnancy and non‐right handedness: meta‐analysis of randomized trials , 2011, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[38] J. Ioannidis,et al. The False-positive to False-negative Ratio in Epidemiologic Studies , 2011, Epidemiology.
[39] Timothy L Lash,et al. Commentary: Should Preregistration of Epidemiologic Study Protocols Become Compulsory? Reflections and a Counterproposal , 2012, Epidemiology.
[40] J. Mclaughlin,et al. False Positives in Cancer Epidemiology , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[41] Sandro Galea,et al. An argument for a consequentialist epidemiology. , 2013, American journal of epidemiology.
[42] Marcia McNutt,et al. Journals unite for reproducibility , 2014, Science.
[43] F. Collins,et al. Policy: NIH plans to enhance reproducibility , 2014, Nature.
[44] Richard F MacLehose,et al. Good practices for quantitative bias analysis. , 2014, International journal of epidemiology.
[45] John P. A. Ioannidis,et al. How to Make More Published Research True , 2014, PLoS medicine.
[46] Harvey J Motulsky,et al. Common Misconceptions about Data Analysis and Statistics , 2014, The Journal of Pharmacology and Experimental Therapeutics.
[47] J. Ioannidis,et al. Reproducibility in Science: Improving the Standard for Basic and Preclinical Research , 2015, Circulation research.
[48] T. Lash. Declining the Transparency and Openness Promotion Guidelines. , 2015, Epidemiology.
[49] T. Lash. Advancing Research through Replication. , 2015, Paediatric and perinatal epidemiology.
[50] S. Buck,et al. Solving reproducibility , 2015, Science.
[51] Brian A. Nosek,et al. Promoting an open research culture , 2015, Science.
[52] Muin J Khoury,et al. Planning for the Future of Epidemiology in the Era of Big Data and Precision Medicine. , 2015, American journal of epidemiology.
[53] Brian A. Nosek,et al. Using prediction markets to estimate the reproducibility of scientific research , 2015, Proceedings of the National Academy of Sciences.
[54] Michael C. Frank,et al. Estimating the reproducibility of psychological science , 2015, Science.
[55] Stavroula A Chrysanthopoulou,et al. Probabilistic bias analysis in pharmacoepidemiology and comparative effectiveness research: a systematic review , 2016, Pharmacoepidemiology and drug safety.
[56] S. Goodman,et al. Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations , 2016, European Journal of Epidemiology.
[57] Yolanda Gil,et al. Enhancing reproducibility for computational methods , 2016, Science.
[58] John P. A. Ioannidis,et al. Reproducible Research Practices and Transparency across the Biomedical Literature , 2016, PLoS biology.
[59] Derek Abbott,et al. Too good to be true: when overwhelming evidence fails to convince , 2016, Proceedings of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[60] J. Ioannidis,et al. Registration practices for observational studies on ClinicalTrials.gov indicated low adherence. , 2016, Journal of clinical epidemiology.
[61] Robert Platt,et al. Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses. , 2016, Journal of clinical epidemiology.
[62] U. Bogdahn,et al. Statin use and risk of glioma: population-based case–control analysis , 2016, European Journal of Epidemiology.
[63] Michelle L Degelman,et al. Smoking and multiple sclerosis: A systematic review and meta-analysis using the Bradford Hill criteria for causation. , 2017, Multiple sclerosis and related disorders.
[64] G. Banks,et al. The Chrysalis Effect , 2017 .
[65] Tara Gomes,et al. Association Between Serotonergic Antidepressant Use During Pregnancy and Autism Spectrum Disorder in Children , 2017, JAMA.
[66] T. Lash,et al. On the Need for Quantitative Bias Analysis in the Peer-Review Process , 2017, American journal of epidemiology.
[67] Stephen R Cole,et al. Transportability of Trial Results Using Inverse Odds of Sampling Weights. , 2017, American journal of epidemiology.
[68] Sander Greenland,et al. Invited Commentary: The Need for Cognitive Science in Methodology , 2017, American journal of epidemiology.
[69] John P. A. Ioannidis,et al. A manifesto for reproducible science , 2017, Nature Human Behaviour.
[70] Harry Crane. Why 'Redefining Statistical Significance' Will Not Improve Reproducibility and Could Make the Replication Crisis Worse , 2017, 1711.07801.
[71] Announcement: Transparency upgrade for Nature journals , 2017, Nature.
[72] Yoshinori Hatori,et al. The Difference between Significant and Non-significant , 2017 .
[73] Manipulating the alpha level cannot cure significance testing – comments on "Redefine statistical significance" , 2017 .
[74] David J. Spiegelhalter,et al. The ASA's p‐value statement, one year on , 2017 .
[75] Lash Responds to "Is Reproducibility Thwarted by Hypothesis Testing?" and "The Need for Cognitive Science in Methodology". , 2017, American journal of epidemiology.
[76] Michael G Hudgens,et al. Generalizing Study Results: A Potential Outcomes Perspective. , 2017, Epidemiology.
[77] Timothy L Lash,et al. The Harm Done to Reproducibility by the Culture of Null Hypothesis Significance Testing. , 2017, American journal of epidemiology.
[78] M. Munafo,et al. Robust research needs many lines of evidence , 2018, Nature.
[80] David Gal,et al. Abandon Statistical Significance , 2017, The American Statistician.